Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06544915 · ClinicalTrials.gov registry record · NA
Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial
A NA study of Blood Pressure, Body Composition, Immune Function, sponsored by Skidmore College.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06544915 is a NA study of Blood Pressure, Body Composition, Immune Function that is actively recruiting participants, run by Skidmore College. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06544915, a NA study of Blood Pressure, Body Composition, Immune Function, is actively recruiting participants, sponsored by Skidmore College.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Accordingly, the purpose of this study is to evaluate the efficacy of 1) supplementation with Synbiotic (Plexus® Triplex), 2) commercially-available Probiotic, or 3) placebo control over 30 days on the gut microbiome, cardiometabolic health, body weight and body composition in healthy individuals.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Synbiotic, Probiotic, Placebo
Study Locations (1)
New York
- Skidmore College - Saratoga Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06544915
The ClinicalTrials.gov registry entry for NCT06544915 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Skidmore College, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Pressure, Body Composition, Immune Function appearing as the primary indexed condition, and to 1 intervention - of which Synbiotic, Probiotic, Placebo is the first listed.
NCT06544915 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06544915 about?
NCT06544915 is a clinical study titled "Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial". Accordingly, the purpose of this study is to evaluate the efficacy of 1) supplementation with Synbiotic (Plexus® Triplex), 2) commercially-available Probiotic, or 3) placebo control over 30 days on the gut microbiome, cardiometabolic health, body weight and body composition in healthy individuals.
What is the current status of trial NCT06544915?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-07-23. Estimated completion is 2025-01-01.
What conditions does trial NCT06544915 study?
This clinical trial studies the following conditions: Blood Pressure, Body Composition, Immune Function.
What interventions are being tested in trial NCT06544915?
The interventions under investigation include: Synbiotic, Probiotic, Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06544915?
This trial is sponsored by Skidmore College, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06544915 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.